Empagliflozin/Metformin Tablet 5/1000 mg
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samsung Pharm. Co., Ltd.
MFDS item code 202201366 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adults with type 2 diabetes, in conjunction with diet and exercise. It is particularly suitable for patients whose blood sugar is not adequately controlled and can also assist in the treatment of patients with concurrent cardiovascular diseases. This medication enhances blood sugar control through the combination of empagliflozin and metformin, improving overall diabetes management. However, considerations related to cardiovascular diseases must be carefully noted as specified in the precautions for use. Such treatment effectively improves patients' blood sugar control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined according to each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients taking this medicine who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps with blood sugar control and is used in diabetes treatment. It can cause a rare side effect called severe lactic acidosis, so patients with poor kidney function or liver problems should not take it. Additionally, caution is required as hypoglycemia may occur when taken with insulin or sulfonylurea medications. Patients with moderate to severe kidney impairment, acute infections, dehydration, heart failure, or acute myocardial infarction should not take this medication. It is necessary to temporarily discontinue this medication before and after diagnostic tests using iodine contrast agents, resuming only after kidney function is confirmed to be normal. Pregnant or breastfeeding women should not take this medication, and it is also not recommended for children under 18 years of age. While taking this medication, side effects may occur, including symptoms of hypoglycemia, urinary infections, genital infections, increased urination, gastrointestinal disturbances; if symptoms appear, patients should inform healthcare professionals immediately. Especially, elderly patients or those at risk of decreased fluid volume should be cautious of dehydration and hypotension and should have regular kidney function tests. There may also be interactions with other medications taken alongside; if other medications are being used, it is essential to inform healthcare professionals. In the event of overdose, serious side effects such as lactic acidosis may occur, and patients should visit a healthcare facility immediately; treatment may require dialysis. This medication should be kept out of reach of children and stored in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The best storage temperature is room temperature between 1 degree and 30 degrees Celsius, to maintain the medication's effectiveness.
Brownish-yellow, biconvex, oval film-coated tablet
10 tablets/box [(10 tablets/PTP×1)], 60 tablets/box [(10 tablets/PTP×6)], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samsung Pharm. Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.